Excess Mortality of Males Due to Malignant Lung Cancer in OECD Countries

Excess mortality of men has been observed since the beginning of the 20th century. One of the main causes of this phenomenon is malignant cancers, with lung cancer as the main reason. At the turn of the 20th and 21st centuries, a decline in male excess mortality was observed in most developed countries. This study aimed to analyze the changes in the level of excess mortality of men caused by lung cancer between 2002 and 2017 in the countries associated with the Organization for Economic Cooperation and Development (OECD). In order to compare changes in male mortality rates across countries, the annual average percent change (AAPC) in male excess mortality rate for a given country was calculated. A decrease in excess male mortality due to lung cancer between 2002 and 2017 was recorded in 33 of the 35 countries analyzed. The highest rate of decline was observed in Spain (4.9% per year), Belgium (4.7% per year), Slovakia (4.4% per year) and other European OECD member countries. In most OECD countries, the decrease in excess male mortality was the result of a decrease in mortality in the male population as well as the increase in female mortality. In 10 member countries of the OECD, there was a simultaneous increase in the mortality of men and women, though the increase was higher in the female population. Only in two countries was the decrease in excess mortality of males due to a greater decline in the mortality of men. The decline in male mortality from lung cancer primarily associated with a reduction in tobacco consumption in this population initiated in the 1980s or 1990s (depending on the country) was not observed in the female population.

Automated summary

The study found that between 2002 and 2017, a decrease in excess male mortality due to lung cancer was recorded in 33 out of 35 OECD member countries. This decrease was primarily due to a reduction in male mortality rates and an increase in female mortality rates.